AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 JAN 18 -- (NewsRx.com) -- A new report from the Research Triangle Institute/University of North Carolina (RTL/UNC) Evidence-Based Practice Center revealed that certain drug therapies and diagnostic tools can have a positive outcome on the treatment of preterm labor.
Researchers reviewed current scientific literature and found evidence proving that the use of tocolytics, drugs that stop uterine contractions, during an episode of preterm labor is an effective means of extending the length of the pregnancy. In contrast, continued use of these medications after contractions have subsided offers no apparent further benefit.
RTI and the University of North Carolina at Chapel Hill conducted the study for the Agency for Healthcare Research and Quality (AHRQ).
Early detection and effective management of preterm labor are important women's health concerns because preterm labor is a common precursor to preterm birth (prior to 37 weeks' gestation). Preterm births represent 11% of all live births, are a leading cause of infant morbidity and mortality, and account for one-third of all health care spending on infants.
Hidden infections of the upper genital tract are believed to be a significant risk factor for ...